p–Aminobenzoic acid derivatives as acetylcholinesterase inhibitors
Authors:
- Iván Vázquez AlcántaraIAIván Vázquez Alcántara
- L. Michel Espinoza-FonsecaLEL. Michel Espinoza-Fonseca
- José G. Trujillo-FerraraJTJosé G. Trujillo-Ferrara
- 1 July 2005
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 40 (7) , 732-735
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Donepezil for the Treatment of Mild to Moderate Alzheimer’s Disease in France: The Economic ImplicationsDementia and Geriatric Cognitive Disorders, 2003
- Synthesis, anticholinesterase activity and structure–Activity relationships of m-Aminobenzoic acid derivativesBioorganic & Medicinal Chemistry Letters, 2003
- Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesteraseEuropean Journal of Pharmaceutical Sciences, 2003
- Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-IIActa Crystallographica Section D Structural Biology, 2000
- Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medicationsInternational Journal of Geriatric Psychiatry, 2000
- Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy functionJournal of Computational Chemistry, 1998
- The ‘aromatic patch’ of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitorsBiochemical Journal, 1998
- Purpuric rash with donepezil treatmentBMJ, 1998
- Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in miceJournal of Toxicology and Environmental Health, 1989
- Ultramicro assay of the cholinesterasesArchives of Biochemistry and Biophysics, 1956